N-Acetyl Mesalazine structure
|
Common Name | N-Acetyl Mesalazine | ||
---|---|---|---|---|
CAS Number | 51-59-2 | Molecular Weight | 195.17 | |
Density | 1.462 g/cm3 | Boiling Point | 480.2ºC at 760 mmHg | |
Molecular Formula | C9H9NO4 | Melting Point | 228-230ºC | |
MSDS | Chinese USA | Flash Point | 244.2ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of N-Acetyl MesalazineN-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the metabolite of 5-Aminosalicylic Acid (HY-15027) with endoscopic activity. N-Acetyl mesalazine can be used for the research of ulcerative colitis[1]. |
Name | 5-acetamido-2-hydroxybenzoic acid |
---|---|
Synonym | More Synonyms |
Description | N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the metabolite of 5-Aminosalicylic Acid (HY-15027) with endoscopic activity. N-Acetyl mesalazine can be used for the research of ulcerative colitis[1]. |
---|---|
Related Catalog | |
References |
Density | 1.462 g/cm3 |
---|---|
Boiling Point | 480.2ºC at 760 mmHg |
Melting Point | 228-230ºC |
Molecular Formula | C9H9NO4 |
Molecular Weight | 195.17 |
Flash Point | 244.2ºC |
Exact Mass | 195.05300 |
PSA | 86.63000 |
LogP | 1.12180 |
Index of Refraction | 1.661 |
Storage condition | 2-8°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H319 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
HS Code | 2924299090 |
~66% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: DAK-Laboratoriet Patent: US4933330 A1, 1990 ; |
~91% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Khan, Md. Umar; Baseer; Kumar, S. Ranjith; Saravanakumar; Prasannanjali; Gupta, P. Badarinadh; Kaushik, Vipin K.; Handa, Vijay K.; Islam, Aminul Synthetic Communications, 2010 , vol. 40, # 15 p. 2241 - 2253 |
~% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Brown, Joseph P.; McGarraugh, Geoff V.; Parkinson, Thomas M.; Wingard, Robert E.; Onderdonk, Andrew B. Journal of Medicinal Chemistry, 1983 , vol. 26, # 9 p. 1300 - 1307 |
~82% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Peng, Yanqing; Song, Gonghua; Ding, Fang Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004 , vol. 43, # 9 p. 2021 - 2023 |
~% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Huebner Justus Liebigs Annalen der Chemie, 1879 , vol. 195, p. 37 |
~% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Huebner Justus Liebigs Annalen der Chemie, 1879 , vol. 195, p. 37 |
~% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Grandmougin Chemische Berichte, 1906 , vol. 39, p. 3930 |
~% N-Acetyl Mesalazine CAS#:51-59-2 |
Literature: Huebner Justus Liebigs Annalen der Chemie, 1879 , vol. 195, p. 37 |
Precursor 8 | |
---|---|
DownStream 4 | |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection.
J. Pharm. Biomed. Anal. 14(1-2) , 175-80, (1995) A high-performance liquid chromatographic method for the simultaneous determination of 5-aminosalicylic acid (5-ASA), acetyl-5-aminosalicylic acid (Ac-5-ASA) and 2,5-dihydroxybenzoic acid (5-HSA) in h... |
|
Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.
J. Pediatr. Gastroenterol. Nutr. 49(5) , 571-9, (2009) : A multicenter, double-blind study was conducted to evaluate the safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate ulcerative colitis (UC).: Sixty-eigh... |
|
Radical-derived oxidation products of 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid.
J. Chromatogr. B, Biomed. Appl. 661(1) , 57-68, (1994) 5-Aminosalicylic acid is an agent effective in the treatment of chronic inflammatory bowel diseases. Its ability to scavenge radicals is considered to be a major factor responsible for its therapeutic... |
CJ 46A |
N-Acetyl Mesalazine |
5-Acetamidosalicylic acid |
N-Acetyl-5-aminosalicylic acid |
3-Carboxyparacetamol |
5-acetylamino salicylic acid |
Acetylmesalazine 5-Acetamidosalicylic acid N-Acetyl-5-aminosalicylic acid |
5-acetamido-2-hydroxy-benzoic acid |